Development and implementation of signs- and symptoms-based insulin adjustment algorithm.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Health-System Pharmacy

• Publication date

  2010-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.2146/ajhp100032PMID 20811025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standards of Medical Care in Diabetes—2010

  2010cited by this paper
• Sulfonylurea receptors and mechanism of sulfonylurea action.

  2009cited by this paper
• The Utility and Recent Advances in Self-Monitoring of Blood Glucose in Type 1 Diabetes

  2008cited by this paper
• Hypoglycaemia in Type 2 diabetes

  2008cited by this paper
• Insulin for type 2 diabetes: choosing a second-line insulin regimen

  2008cited by this paper
• Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

  2007cited by this paper
• Standards of Medical Care in Diabetes: Response to Power

  2006cited by this paper
• Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study.

  2003cited by this paper
• Provider-patient interaction in diabetes care: effects on patient self-care and outcomes. A systematic review.

  2003cited by this paper
• Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: A cross sectional study

  2003cited by this paper
• Self-Monitoring of Blood Glucose: The Basics

  2002cited by this paper
• Ellenberg and Rifkin's Diabetes Mellitus

  2002cited by this paper
• Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes.

  2000cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Metformin Improves Glucose, Lipid Metabolism, and Reduces Blood Pressure in Hypertensive, Obese Women

  1993cited by this paper
• The sulfonylurea receptor.

  1992cited by this paper
• Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM Patients

  1990cited by this paper

• Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial

  2020cites this paper
• Cost‐effectiveness of multidisciplinary collaborative care versus usual care in the management of high‐risk patients with diabetes in Singapore: Short‐term results from a randomized controlled trial

  2018cites this paper
• Review of insulin‐associated hypoglycemia and its impact on the management of diabetes in Southeast Asian countries

  2017cites this paper
• Impact of pharmacist‐involved collaborative care on the clinical, humanistic and cost outcomes of high‐risk patients with type 2 diabetes (IMPACT): a randomized controlled trial

  2017cites this paper
• Metabolic parameters in type 2 diabetic patients with varying degrees of glycemic control during Ramadan: An observational study

  2015cites this paper
• “Symptom-based Insulin adjustment for Glucose Normalization” (SIGN) Algorithm: A Pilot Study

  2012influential citation
• Recent Publications on Medications and Pharmacy

  2011cites this paper